Skip to main content
Contact Us
Subscribe
E-Edition
52°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Crescita Therapeutics Inc
(TSX:
CTX
)
0.5600
UNCHANGED
Streaming Delayed Price
Updated: 12:58 PM EST, Dec 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Crescita Therapeutics Inc
< Previous
1
2
Next >
Crescita Reports Third Quarter 2024 Results
November 06, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
September 24, 2024
From
Crescita Therapeutics
Via
Business Wire
Keynotes and 50 Companies to Present at the Planet MicroCap Showcase: VANCOUVER in association with Small Cap Discoveries on September 25-26, 2024 at the Fairmont Waterfront Vancouver
September 24, 2024
Via
ACCESSWIRE
Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024
September 12, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports Second Quarter 2024 Results
August 07, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years
July 22, 2024
From
Crescita Therapeutics
Via
Business Wire
Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement
July 19, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device
July 17, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Completes Acquisition of Strategic Assets of Occy Laboratory
June 26, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita to Acquire Strategic Assets of Occy Laboratory
June 20, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
June 06, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports First Quarter 2024 Results
May 08, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports Q4 and Fiscal 2023 Results
March 13, 2024
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports Third Quarter 2023 Results
November 08, 2023
From
Crescita Therapeutics Inc.
Via
Business Wire
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
August 29, 2023
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports Second Quarter 2023 Results
August 09, 2023
From
Crescita Therapeutics
Via
Business Wire
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
June 21, 2023
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports First Quarter 2023 Results
May 11, 2023
From
Crescita Therapeutics Inc.
Via
Business Wire
Crescita Reports Q4 and Fiscal 2022 Results
March 15, 2023
From
Crescita Therapeutics Inc.
Via
Business Wire
Crescita Reports Third Quarter 2022 Results
November 09, 2022
From
Crescita Therapeutics Inc.
Via
Business Wire
Crescita Reports Second Quarter 2022 Results
August 10, 2022
From
Crescita Therapeutics Inc.
Via
Business Wire
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
May 12, 2022
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports First Quarter 2022 Results
May 11, 2022
From
Crescita Therapeutics
Via
Business Wire
Crescita to Present at Bloom Burton & Co. Healthcare Investor Conference
April 21, 2022
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports Q4 and Fiscal 2021 Results
March 23, 2022
From
Crescita Therapeutics Inc.
Via
Business Wire
Crescita Therapeutics Announces Renewal of Normal Course Issuer Bid
December 15, 2021
From
Crescita Therapeutics
Via
Business Wire
Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis®
December 13, 2021
From
Crescita Therapeutics
Via
Business Wire
Crescita Reports Third Quarter 2021 Results and Appoints New Board Member
November 11, 2021
From
Crescita Therapeutics
Via
Business Wire
Crescita Announces Exclusive Canadian Distribution Agreement with Obagi Cosmeceuticals LLC
September 09, 2021
From
Crescita Therapeutics
Via
Business Wire
Crescita Acquires Minority Interest in The Best You®
September 07, 2021
From
Crescita Therapeutics Inc.
Via
Business Wire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
